NCT03559387 2019-02-12Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced NeutropeniaProlong PharmaceuticalsPhase 2 Terminated9 enrolled